SCOPUS 정보 검색 플랫폼

Clinical Neuropharmacology

Volumn 24, Issue 5, 2001, Pages 247-253

Choosing dopamine agonists in Parkinson's disease

(2) Tan, Eng King a Jankovic, Joseph a

a BAYLOR COLLEGE OF MEDICINE (United States)

Author keywords

Bromocriptine; Dopamine agonists; Parkinson's disease; Pergolide; Pramipexole; Ropinirole

Indexed keywords

ANTIPARKINSON AGENT; BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; LISURIDE; PERGOLIDE; PLACEBO; PRAMIPEXOLE; ROPINIROLE;

BINDING AFFINITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG PREFERENCE; DRUG RECEPTOR BINDING; DRUG SAFETY; DYSKINESIA; HUMAN; INSOMNIA; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; NEUROLOGIC DISEASE; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROPERITONEAL FIBROSIS; REVIEW; SINGLE BLIND PROCEDURE; TRAFFIC ACCIDENT; TREATMENT PLANNING;

ANIMALS; CLINICAL TRIALS; DOPAMINE AGONISTS; HUMANS; PARKINSON DISEASE; RECEPTORS, DOPAMINE;

EID: 0034801739 PISSN: 03625664 EISSN: None Source Type: Journal
DOI: 10.1097/00002826-200109000-00001 Document Type: Review

Times cited : (33)

References (44)

1
- 0032737058
- Treatment of Parkinson's disease should begin with a dopamine agonist
- (1999) Mov Disord , vol.14 , pp. 725-730
- Montastruc, J.L.¹ Rascol, O.² Senard, J.M.³

2
- 0002870062
- Therapeutic strategies in Parkinson's disease
- Jankovic J, Tolosa E, eds. Baltimore: Williams and Wilkins
- (1998) Parkinson's Disease and Movement Disorders, 3rd edition , pp. 191-220
- Jankovic, J.¹ Marsden, C.D.²

3
- 0031716026
- Dopamine agonists and neuroprotection in Parkinson's disease
- (1998) Ann Neurol , vol.44 , Issue.SUPPL.
- Olanow, C.W.¹ Jenner, P.² Brooks, D.³

4
- 0033525427
- Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity
- (1999) Life Sci , vol.64 , pp. 1275-1285
- Zou, L.¹ Jankovic, J.² Rowe, D.B.³

5
- 0034682308
- A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa
- 056 Study Group
- (2000) N Engl J Med , vol.18 , pp. 1484-1491
- Rascol, O.¹ Brooks, D.J.² Korczyn, A.D.³

6
- 0034684139
- Pramipexole versus levodopa as initial treatment for Parkinson's disease: A randomized controlled trial
- (2000) JAMA , vol.284 , pp. 1931-1938

7
- 0026543545
- Molecular biology of dopamine receptors
- (1992) Trends Pharmacol Sci , vol.13 , pp. 61-69
- Sibley, D.R.¹ Monsma, F.J.²

8
- 6844250767
- Dopamine structure: From structure to function
- (1998) Physiol Rev , vol.78 , pp. 189-225
- Missale, C.¹ Nash, S.R.² Robinson, S.W.³

9
- 0034000344
- Dopamine receptors: Novel insights from biochemical and genetic studies
- (2000) Neuroscientist , vol.6 , pp. 127-138
- Schmauss, C.¹

10
- 0034086001
- Dopamine receptors and locomotor responses: Molecular aspects
- (2000) Ann Neurol , vol.47
- Sealfon, S.C.¹

11
- 0034927015
- A comparison of the therapeutic efficacy of pergolide and pramipexole in Parkinson's disease
- (2001) J Neural Transm , vol.108 , pp. 63-70
- Hanna, P.A.¹ Ratkos, L.² Ondo, W.G.³

12
- 0033595201
- A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson's disease
- (1999) Neurology , vol.53 , pp. 364-370
- Korczyn, A.D.¹ Brunt, E.R.² Larsen, J.P.³

13
- 0032918088
- Switching dopamine agonists in advanced Parkinson's disease: Is fast titration preferable to slow?
- (1999) Neurology , vol.52 , pp. 1227-1229
- Goetz, C.G.¹ Blasucci, L.² Stebbins, G.T.³

14
- 0032700713
- An overnight switch to ropinirole therapy in patients with Parkinson's disease
- (1999) J Neural Transm , vol.106 , pp. 925-929
- Canesi, M.¹ Antonini, A.² Mariani, C.B.³

15
- 0031975683
- Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6-month interim report of a 3-year study
- 053 Study Group
- (1998) Mov Disord , vol.13 , pp. 46-51
- Korczyn, A.D.¹ Brooks, D.J.² Brunt, E.R.³

16
- 0030726156
- Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease
- International Pramipexole-Bromocriptine Study Group
- (1997) Neurology , vol.49 , pp. 1060-1065
- Guttman, M.¹

17
- 0029839676
- Double-blind comparison of cabergoline and bromocriptine in Parkinson's disease patients with motor fluctuations
- (1996) Neurology , vol.47 , pp. 785-788
- Inzelberg, R.¹ Nisipeanu, P.² Rabey, J.M.³

18
- 0042120031
- Pergolide in the treatment of Parkinson's disease
- (1995) Neurology , vol.45
- Mizuno, Y.¹ Kondo, T.² Narabayashi, H.³

19
- 0028108776
- Pergolide compared with bromocriptine in Parkinson's disease: A multicenter, crossover, controlled study
- (1994) Mov Disord , vol.9 , pp. 431-436
- Pezzoli, G.¹ Martignoni, E.² Pacchetti, C.³

20
- 0026619099
- Comparison of lisuride and bromocriptine in the treatment of advanced Parkinson's disease
- (1992) Acta Neurol Scand , vol.86 , pp. 593-595
- Laihinen, A.¹ Rinne, U.K.² Suchy, I.³

21
- 0024446594
- Agonist substitution in advanced Parkinson's disease
- (1989) Neurology , vol.39 , pp. 1121-1122
- Goetz, C.G.¹ Shannon, K.M.² Tanner, C.M.³

22
- 0021874692
- Chronic agonist therapy for Parkinson's disease: A 5-year study of bromocriptine and pergolide
- (1985) Neurology , vol.35 , pp. 749-751
- Goetz, C.G.¹ Tanner, C.M.² Glantz, R.H.³

23
- 0020627065
- Comparison of pergolide and bromocriptine therapy in parkinsonism
- (1983) Neurology , vol.33 , pp. 1009-1014
- LeWitt, P.A.¹ Ward, C.D.² Larsen, T.A.³

24
- 0020082518
- Lisuride versus bromocriptine treatment in Parkinson's disease: A double-blind study
- (1982) Neurology , vol.32 , pp. 69-72
- LeWitt, P.A.¹ Gopinathan, G.² Ward, C.D.³

25
- 0033026623
- Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors
- (1999) Eur J Pharmacol , vol.366 , pp. 293-300
- Perachon, S.¹ Schwartz, J.C.² Sokoloff, P.³

26
- 0033019985
- ABT-431, a D1 receptor agonist has efficacy in Parkinson's disease
- (1999) Ann Neurol , vol.45 , pp. 736-741
- Rascol, O.¹ Blin, O.² Thalamas, C.³

27
- 0032759176
- Treatment of Parkinson's disease with ropinirole after pergolide-induced retroperitoneal fibrosis
- (1999) Pharmacotherapy , vol.19 , pp. 1437-1438
- Lund, B.C.¹ Neiman, R.F.² Perry, P.J.³

28
- 0034073543
- Clinical characteristics of pramipexole-induced peripheral edema
- (2000) Arch Neurol , vol.57 , pp. 729-732
- Tan, E.K.¹ Ondo, W.²

29
- 0035119862
- The long-term safety and efficacy of pramipexole in advanced Parkinson's disease
- (2001) Parkinsonism Rel Disord , vol.7 , pp. 115-120
- Weiner, W.J.¹ Factor, S.A.² Jankovic, J.³

30
- 0032975093
- Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole
- (1999) Neurology , vol.52 , pp. 1908-1910
- Frucht, S.¹ Rogers, J.D.² Greene, P.E.³

31
- 0003305875
- Sleep disorders in patients with Parkinson's disease
- in press
- (2001) Neurology
- Ondo, W.G.¹ Vuong, K.V.² Khan, H.³

32
- 0034924694
- A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy
- (2001) J Neurol Transm , vol.108 , pp. 71-77
- Pal, S.¹ Bhattacharya, K.F.² Agapito, C.³

33
- 0034654935
- Sleep attacks and Parkinson's disease treatment
- (2000) Lancet , vol.355 , pp. 1333-1334
- Ferreira, J.J.¹ Galitzky, M.² Montastruc, J.L.³

34
- 0034007549
- Comparison of pramipexole, fluoxetine, and placebo in patients with major depression
- (2000) Depress Anxiety , vol.11 , pp. 58-65
- Corrigan, M.H.¹ Denahan, A.Q.² Wright, C.E.³

35
- 0032936809
- Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease
- (1999) Eur J Clin Pharmacol , vol.55 , pp. 299-303
- Thalamus, C.¹ Taylor, A.² Brefel-Courbon, C.³

36
- 0030988731
- Steady-state pharmacokinetic properties of pramipexole in healthy volunteers
- (1997) J Clin Pharmacol , vol.37 , pp. 520-525
- Wright, C.E.¹ Sisson, T.L.² Ichhpurani, A.K.³

37
- 0031976069
- The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease
- (1998) Drugs , vol.55
- Chase, T.N.¹

38
- 0033695789
- Continuous dopamine-receptor stimulation in early Parkinson's disease
- (2000) Trends Neurosci , Issue.SUPPL.
- Olanow, C.W.¹ Schapira, A.H.V.² Rascol, O.³

39
- 0033797572
- Sustained cabergoline treatment reverses levodopa-induced dyskinesias in parkinsonian monkeys
- (2000) Clin Neuropharmacol , vol.23 , pp. 195-202
- Tahar, A.H.¹ Gregoire, L.² Bangassoro, E.³

40
- 0033453238
- Sublingual apomorphine in patients with fluctuating Parkinson's disease
- (1999) Mov Disord , vol.14 , pp. 664-668
- Ondo, W.¹ Hunter, C.² Almaguer, M.³

41
- 0031656485
- N-0923, a novel soluble dopamine D2 in the treatment of parkinsonism
- (1998) Mov Disord , vol.13 , pp. 768-774
- Calabrese, V.P.¹ Lloyd, K.A.² Brancazio, P.³

42
- 0033455618
- A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease
- (1999) Mov Disord , vol.14 , pp. 336-341
- Montastruc, J.L.¹ Ziegler, M.² Rascol, O.³

43
- 0034745615
- Induction by doparainc D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson's disease
- (2001) Arch Neurol , vol.58 , pp. 249-254
- Rascol, O.¹ Nutt, J.G.² Blin, O.³

44
- 0026770776
- Activity and acceptability of piribedil in Parkinson's disease: A multicentre study
- (1992) J Neurol , vol.239 , Issue.SUPPL. 1
- Rondot, P.¹ Ziegler, M.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.